MCPIP1 and MCPIP3 (Regnase-1 and Regnase-3) are members of an RNA-binding endonuclease family involved in post-transcriptional regulation of gene expression, yet their roles in epidermal homeostasis and tumorigenesis remain distinct. In the skin, MCPIP1 is predominantly expressed in suprabasal differentiating keratinocytes. Keratinocyte-specific deletion of MCPIP1 disrupts epidermal homeostasis and markedly promotes DMBA/TPA-induced carcinogenesis, resulting in earlier tumor development, increased tumor burden, and a highly aggressive squamous phenotype. MCPIP1 RNase activity increases the expression of inflammation and tumor-associated transcripts. In contrast, loss of MCPIP3 causes epidermal hyperplasia and dysregulated differentiation. Predominantly expressed in basal KRT14-positive keratinocytes, MCPIP3 is markedly upregulated in human cutaneous squamous cell carcinoma. Its loss results in less aggressive chemically induced tumors and remodels the tumor immune microenvironment by enhancing interferon-related signaling, antigen presentation, cytotoxic responses, and IL-33/CXCL10-associated pathways. Together, these findings reveal distinct, non-redundant roles for MCPIP1 and MCPIP3 in epidermal homeostasis and skin tumorigenesis
Jolanta Jura completed her studies in biology in 1990 in Toruń (birth place of Copernicus). In 1994, she earned a PhD in biological sciences from the K. Marcinkowski Medical Academy in Poznań. In 2000 she moved to the University of Krakow and became in 2014 professor at the Department of General Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow. She has completed numerous research fellowships, including stays in Germany, the United Kingdom, Italy, and at Brigham and Women’s Hospital (Harvard Medical School, USA). Since 2020 she is dean of the Faculty of Biochemistry, Biophysics and Biotechnology at Jagiellonian University. Her earlier research focused on the analysis of mutations and the identification of genes responsible for genetic diseases. Her current work focuses on the molecular mechanisms regulating inflammation and their role in metabolic diseases, cancer, and skin disorders. Currently she is working mainly on the activities of MCPIP family members (MCPIP1 is also known as Regnase) and N4BP1. N4BP1 (NEDD4-binding protein 1) is a human interferon-inducible negative regulator of innate immunity and an RNA-binding endoribonuclease.